H. Malluche

发表

Characterization of a response element in the 5'-flanking region of the avian (chicken) PTH gene that mediates negative regulation of gene transcription by 1,25-dihydroxyvitamin D3 and binds the vitamin D3 receptor.

S. Liu, N. Koszewski, M. Lupez, 1996, Molecular endocrinology.

Bone histomorphometry: Standardization of nomenclature, symbols, and units: Report of the asbmr histomorphometry nomenclature committee

M. Drezner, J. Kanis, F. Glorieux, 1987, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Early chronic kidney disease-mineral bone disorder stimulates vascular calcification

K. Hruska, H. Malluche, Yifu Fang, 2013, Kidney international.

Effects of Sucroferric Oxyhydroxide Compared to Lanthanum Carbonate and Sevelamer Carbonate on Phosphate Homeostasis and Vascular Calcifications in a Rat Model of Chronic Kidney Failure

M. Burnier, M. Maillard, J. Stehle, 2015, BioMed research international.

Isolation and complete amino acid sequence of osteocalcin from canine bone

H. Malluche, P. Fanti, G. Colombo, 1993, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

The use of deferoxamine in the management of aluminium accumulation in bone in patients with renal failure.

H. Malluche, K. Abreo, A. Smith, 1984, The New England journal of medicine.

Sotatercept Safety and Effects on Hemoglobin, Bone, and Vascular Calcification

K. Hruska, H. Malluche, D. Coyne, 2019, Kidney international reports.

BONE COMPLICATIONS AND CALCIFICATION OF SOFT TISSUES IN CHRONIC KIDNEY DISEASE

H. Malluche, J. Middleton, 2007 .

Oncogenic Osteomalacia Associated with Metastatic Prostate Carcinoma: Case Report and Review of the Literature

C. McMurtry, R. Adler, H. Malluche, 1993, Journal of the American Geriatrics Society.

K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease.

Keith C. Norris, A. Gotto, G. Eknoyan, 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Moderately high consumption of ethanol suppresses bone resorption in ovariectomized but not in sexually intact adult female rats.

H. Malluche, P. Fanti, M. Monier‐Faugere, 1997, Alcoholism, clinical and experimental research.

Differences in bone turnover and intact PTH levels between African American and Caucasian patients with end-stage renal disease.

H. Malluche, P. Fanti, M. Monier‐Faugere, 2003, Kidney international.

The Effect of Class A Scavenger Receptor Deficiency in Bone*

T. Nagy, S. Post, H. Malluche, 2007, Journal of Biological Chemistry.

Influence of the parathyroid glands on bone metabolism

N. Koszewski, H. Malluche, J. Williams, 2006, European journal of clinical investigation.

Femoral bone mineral density reflects histologically determined cortical bone volume in hemodialysis patients

A. Branscum, H. Malluche, M. Monier‐Faugere, 2010, Osteoporosis International.

Five-year postoperative results of cemented femoral arthroplasty in patients with systemic bone disease.

L. Dorr, H. Malluche, I. Arnala, 1990, Clinical orthopaedics and related research.

Effects of sevelamer hydrochloride and calcium carbonate on renal osteodystrophy in hemodialysis patients.

Aníbal Ferreira, H. Malluche, C. Gil, 2008, Journal of the American Society of Nephrology : JASN.

The Role of Alterations in Alpha-Klotho and FGF-23 in Kidney Transplantation and Kidney Donation

Javier A. Neyra, J. Neyra, H. Malluche, 2022, Frontiers in Medicine.

Renal osteodystrophy in the first decade of the new millennium: Analysis of 630 bone biopsies in black and white patients

H. Malluche, M. Monier‐Faugere, H. Mawad, 2011, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Chapter 8 – Bone Biopsies: A Modern Approach

H. Malluche, M. Monier‐Faugere, M. C. Langub, 1998 .

Transactivation of the parathyroid hormone promoter by specificity proteins and the nuclear factor Y complex.

N. Koszewski, H. Malluche, K. Sarge, 2005, Endocrinology.

Stiffness and strength of bone in osteoporotic patients treated with varying durations of oral bisphosphonates

H. Malluche, D. Pienkowski, K. Rouch, 2016, Osteoporosis International.

High Parathyroid Hormone Level and Osteoporosis Predict Progression of Coronary Artery Calcification in Patients on Dialysis.

H. Malluche, D. Davenport, M. Monier‐Faugere, 2015, Journal of the American Society of Nephrology : JASN.

The link between bone and coronary calcifications in CKD-5 patients on haemodialysis.

A. Branscum, H. Malluche, E. Ok, 2011, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Low bone volume--a risk factor for coronary calcifications in hemodialysis patients.

A. Branscum, Aníbal Ferreira, H. Malluche, 2009, Clinical journal of the American Society of Nephrology : CJASN.

Paracrine Overexpression of IGFBP‐4 in Osteoblasts of Transgenic Mice Decreases Bone Turnover and Causes Global Growth Retardation

T. Clemens, C. Rosen, H. Malluche, 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Iga nephropathy: presentation, clinical course, and prognosis in children and adults.

B. Julian, R. Wyatt, H. Malluche, 1984, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Bone Markers Predict Cardiovascular Events in Chronic Kidney Disease

S. Browning, H. Holzer, H. Malluche, 2008, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Coronary artery calcification in CKD-5D patients is tied to adverse cardiac function and increased mortality

V. Sorrell, H. Malluche, D. Davenport, 2016, Clinical nephrology.

Biomarkers of Bone Turnover Identify Subsets of Chronic Kidney Disease Patients at Higher Risk for Fracture.

S. Kritchevsky, D. Bauer, M. Shlipak, 2020, The Journal of clinical endocrinology and metabolism.

Bone disease after renal transplantation

H. Malluche, M. Monier‐Faugere, J. Herberth, 2010, Nature Reviews Nephrology.

Bone histology in incipient and advanced renal failure.

E. Ritz, H. Malluche, W. Schoeppe, 1976, Kidney international.

Predictive value of serum parathyroid hormone levels for bone turnover in patients on chronic maintenance dialysis.

H. Malluche, M. Monier‐Faugere, Z. Geng, 1995, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Long‐term outcomes and management considerations after parathyroidectomy in the dialysis patient

H. Malluche, M. Rao, B. Sawaya, 2019, Seminars in dialysis.

Reduction of Dialysate Calcium Level Reduces Progression of Coronary Artery Calcification and Improves Low Bone Turnover in Patients on Hemodialysis.

H. Malluche, F. Kirçelli, E. Ok, 2016, Journal of the American Society of Nephrology : JASN.

TREATMENT OPTIONS IN THE MANAGEMENT OF PHOSPHATE RETENTION

H. Malluche, G. Porter, 2007 .

Osteoblast-specific Knockout of the Insulin-like Growth Factor (IGF) Receptor Gene Reveals an Essential Role of IGF Signaling in Bone Matrix Mineralization*

M. Bouxsein, S. Xuan, T. Clemens, 2002, The Journal of Biological Chemistry.

SP645QUANTITATIVE COMPUTED TOMOGRAPHY RESULTS FOR BONE MASS AND ABDOMINAL AORTIC VASCULAR CALCIFICATION IN HEMODIALYSIS SUBJECTS TREATED WITH ESCALATING DOSE LEVELS OF SOTATERCEPT: INTERIM ANALYSIS OF ACE-011-REN-001

K. Hruska, H. Malluche, William T. Smith, 2015 .

Bone biopsy in patients with osteoporosis

H. Malluche, M. Monier‐Faugere, H. Mawad, 2007, Current osteoporosis reports.

Bone mineral density and serum biochemical predictors of bone loss in patients with CKD on dialysis.

H. Malluche, D. Davenport, M. Monier‐Faugere, 2014, Clinical journal of the American Society of Nephrology : CJASN.

Diagnosis, assessment, and treatment of bone turnover abnormalities in renal osteodystrophy.

S. Massry, L. Mccann, H. Malluche, 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Serum bone markers in ROD patients across the spectrum of decreases in GFR: Activin A increases before all other markers

H. Malluche, D. Davenport, A. El-Husseini, 2019, Clinical nephrology.

Bone alkaline phosphatase isoforms in hemodialysis patients with low versus non-low bone turnover: a diagnostic test study.

H. Malluche, M. Monier‐Faugere, P. Magnusson, 2015, American journal of kidney diseases : the official journal of the National Kidney Foundation.

FGF-23 serum levels and bone histomorphometric results in adult patients with chronic kidney disease on dialysis

H. Malluche, M. Monier‐Faugere, V. David, 2014, Clinical nephrology.

Low-energy fractures without low T-scores characteristic of osteoporosis: a possible bone matrix disorder.

H. Malluche, D. Pienkowski, M. Monier‐Faugere, 2013, The Journal of bone and joint surgery. American volume.

Prevention of bone loss in renal transplant recipients: a prospective, randomized trial of intravenous pamidronate.

H. Malluche, S. Greenstein, D. Glicklich, 2003, Journal of the American Society of Nephrology : JASN.

Parathyroid Hormone/Parathyroid Hormone‐Related Peptide Type 1 Receptor in Human Bone

N. Koszewski, H. Malluche, M. Monier‐Faugere, 2001, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

22-oxacalcitriol suppresses secondary hyperparathyroidism without inducing low bone turnover in dogs with renal failure.

H. Malluche, E. Slatopolsky, M. Monier‐Faugere, 1999, Kidney international.

The Phytoestrogen Genistein Reduces Bone Loss in Short-Term Ovariectomized Rats

P. Morris, H. Malluche, P. Fanti, 1998, Osteoporosis International.

Bone resorption and mRNA expression of IL-6 and IL-6 receptor in patients with renal osteodystrophy.

N. Koszewski, H. Malluche, M. Monier‐Faugere, 1996, Kidney international.

Atlas of Mineralized Bone Histology

H. Malluche, M. Faugere, 1986 .

Only minor differences in renal osteodystrophy features between wild-type and sclerostin knockout mice with chronic kidney disease.

D. Pahr, H. Malluche, R. Marculescu, 2016, Kidney international.

Increased bone adiposity and peroxisomal proliferator-activated receptor-gamma2 expression in type I diabetic mice.

M. Orth, H. Malluche, L. McCabe, 2005, Endocrinology.

Skeletal abnormalities in chronic renal insufficiency before and during maintenance hemodialysis.

E. Ritz, H. Malluche, O. Mehls, 1973, Kidney international.

Diagnosis of low bone mass in CKD-5D patients

H. Malluche, D. Davenport, M. Monier‐Faugere, 2015, Clinical nephrology.

Histologic Abnormalities of Bone before and after Kidney Transplantation

H. Malluche, M. Monier‐Faugere, 2005 .

1,25-Dihydroxyvitamin D maintains bone cell activity, and parathyroid hormone modulates bone cell number in dogs.

H. Malluche, P. Fanti, C. Matthews, 1986, Endocrinology.

Ligand trap of the activin receptor type IIA inhibits osteoclast stimulation of bone remodeling in diabetic mice with chronic kidney disease.

Joseph M. Wallace, K. Hruska, H. Malluche, 2017, Kidney international.

Relationship between bone histology and markers of bone and mineral metabolism in African-American hemodialysis patients.

D. Rao, J. Yee, H. Malluche, 2009, Clinical journal of the American Society of Nephrology : CJASN.

The five most commonly used intact parathyroid hormone assays are useful for screening but not for diagnosing bone turnover abnormalities in CKD-5 patients.

A. Branscum, H. Malluche, M. Monier‐Faugere, 2009, Clinical nephrology.

Effects of treatment of renal osteodystrophy on bone histology.

H. Malluche, M. Monier‐Faugere, H. Mawad, 2008, Clinical journal of the American Society of Nephrology : CJASN.

Utilization of bone histomorphometry in renal osteodystrophy: demonstration of a new approach using data from a prospective study of lanthanum carbonate.

H. Malluche, T. Freemont, 2005, Clinical nephrology.

REGULATION OF PHOSPHATE IN HEALTH AND DISEASE * —

H. Malluche, W. Finn, 2007 .

High prevalence of low bone turnover and occurrence of osteomalacia after kidney transplantation.

H. Malluche, M. Monier‐Faugere, H. Mawad, 2000, Journal of the American Society of Nephrology : JASN.

Prevalence of low bone formation in untreated patients with osteoporosis

H. Malluche, M. Monier‐Faugere, Florence Lima, 2022, PloS one.

Prevention of p.o. clotting of av. cimino fistulae with Acetylsalicyl acid results of a prospective double blind study

E. Ritz, H. Malluche, K. Andrassy, 1974, Klinische Wochenschrift.

An assessment of cinacalcet HCl effects on bone histology in dialysis patients with secondary hyperparathyroidism.

H. Malluche, W. Goodman, J. Coburn, 2008, Clinical nephrology.

Plasma levels of bone Gla-protein reflect bone formation in patients on chronic maintenance dialysis.

H. Malluche, P. Fanti, P. Price, 1984, Kidney international.

Renal bone disease 1990: an unmet challenge for the nephrologist.

H. Malluche, M. Faugere, 1990, Kidney international.

Improvements in renal osteodystrophy in patients treated with lanthanum carbonate for two years.

H. Malluche, C. Swanepoel, M. Monier‐Faugere, 2008, Clinical nephrology.

Biochemical Evidence of Metabolic Bone Disease in Women Following Roux-Y Gastric Bypass for Morbid Obesity

F. S. Whaley, W. Strodel, H. Malluche, 1992, Obesity surgery.

The new kidney disease: improving global outcomes (KDIGO) guidelines - expert clinical focus on bone and vascular calcification.

K. Hruska, H. Malluche, D. Coyne, 2010, Clinical nephrology.

Management of hyperphosphataemia of chronic kidney disease: lessons from the past and future directions.

H. Malluche, H. Mawad, 2002, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Dialysis: current status, contemporary limitations and future challenges.

H. Malluche, B. Sawaya, M. Faugere, 1995, Kidney international. Supplement.

Development and characterization of a polyclonal antiserum-based radioimmunoassay for dog osteocalcin

H. Malluche, Stephen P. A. Brown, P. Fanti, 2009 .

24R,25-Dihydroxyvitamin D3 and 1 alpha,25-dihydroxyvitamin D3 are both indispensable for calcium and phosphorus homeostasis.

A. Norman, H. Malluche, H. Henry, 1980, Life sciences.

Animal Models for Osteoporosis

H. Malluche, J. B. Rodgers, 1994 .

Treatment with pyrophosphate inhibits uremic vascular calcification.

W. C. O'Neill, H. Malluche, K. Lomashvili, 2011, Kidney international.

Effect of bisphosphonates on vascular calcification and bone metabolism in experimental renal failure.

W. C. O'Neill, Xiaonan H. Wang, H. Malluche, 2009, Kidney international.

Treatment of aluminum toxicity in infantile uremia with deferoxamine.

H. Malluche, G. Zilleruelo, J. Strauss, 1986, The Journal of pediatrics.

Vitamin D receptor interactions with positive and negative DNA response elements: an interference footprint comparison

N. Koszewski, H. Malluche, J. Russell, 2000, The Journal of Steroid Biochemistry and Molecular Biology.

Administration of PTH-(7-84) antagonizes the effects of PTH-(1-84) on bone in rats with moderate renal failure.

N. Koszewski, H. Malluche, M. Monier‐Faugere, 2003, Endocrinology.

Regulation of 25‐hydroxyvitamin D3 metabolism in cultures of osteoblastic cells

R. Letton, H. Malluche, P. Fanti, 1990, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

1,25(OH)2D3 administration in moderate renal failure: a prospective double-blind trial.

H. Malluche, P. Fanti, M. Faugere, 1989, Kidney international.

Calcitriol in prolonged hypocalcemia due to the tumor lysis syndrome.

H. Malluche, P. Fanti, M. Allon, 1989, Annals of internal medicine.

Calcitriol, parathyroid hormone, and accumulation of aluminum in bone in dogs with renal failure.

H. Malluche, P. Fanti, C. Matthews, 1987, The Journal of clinical investigation.

Renal Osteodystrophy Is a Multifaceted Disease with No Uniform Therapy

H. Malluche, B. Sawaya, 1993 .

Selectivity of a C-terminal peptide antiserum for different DNA-binding states of the vitamin D receptor.

N. Koszewski, H. Malluche, R. Horst, 1998, Archives of biochemistry and biophysics.

Skeletal X-ray findings and bone histology in patients on hemodialysis.

E. Ritz, H. Malluche, B. Krempien, 1978, Kidney international.

Opposite effects of calcitriol and paricalcitol on the parathyroid hormone-(1-84)/large carboxy-terminal-parathyroid hormone fragments ratio in patients with stage 5 chronic kidney disease.

H. Malluche, M. Monier‐Faugere, H. Mawad, 2007, Clinical journal of the American Society of Nephrology : CJASN.

Calcific uremic arteriolopathy in association with low turnover uremic bone disease.

H. Malluche, B. Sawaya, H. Mawad, 1999, Clinical nephrology.

Changes of bone histology during maintenance hemodialysis at various levels of dialyzate Ca concentration.

E. Ritz, H. Malluche, W. Schoeppe, 1976, Clinical nephrology.

Interventional Nephrology and Dialysis: Bone Biopsy: Indications, Techniques, and Complications

H. Malluche, B. Sawaya, H. Mawad, 2003 .

Pth 1-84, Pth fragments and bone turnover.

H. Malluche, M. Monier‐Faugere, 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

B. Julian, H. Malluche, P. Fanti, 1986, American journal of nephrology.

Renal osteodystrophy.

H. Malluche, M. Faugere, 1989, The New England journal of medicine.

Bone biopsy: indications, techniques, and complications.

H. Malluche, B. Sawaya, H. Mawad, 2003, Seminars in dialysis.

6 Bone Biopsy

H. Malluche, M. Faugere, 1986 .

Early therapy of renal bone disease with calcitriol: a prospective double-blind study.

H. Malluche, P. Fanti, M. Faugere, 1989, Kidney international. Supplement.

INFANT FORMULA AS A CAUSE OF ALUMINIUM TOXICITY IN NEONATAL URAEMIA

H. Malluche, G. Zilleruelo, J. Strauss, 1985, The Lancet.

Loss of bone resulting from accumulation of aluminum in bone of patients undergoing dialysis.

E. Ritz, H. Malluche, I. Arnala, 1986, The Journal of laboratory and clinical medicine.

Renal osteodystrophy: what's in a name? Presentation of a clinically useful new model to interpret bone histologic findings.

H. Malluche, M. Monier‐Faugere, Monier-Faugere Mc, 2006, Clinical nephrology.

A program package for quantitative analysis of histologic structure and remodeling dynamics of bone.

H. Malluche, R. C. Manaka, 1981, Computer programs in biomedicine.

Animal models for the study of bone loss after cessation of ovarian function.

H. Malluche, M. Monier‐Faugere, J. B. Rodgers, 1993, Bone.

Quantitative bone histology in 84 normal American subjects

S. Massry, H. Malluche, D. Sherman, 1982, Calcified Tissue International.

Comparison of different bone-biopsy techniques for qualitative and quantitative diagnosis of metabolic bone diseases.

H. Malluche, M. Faugere, 1983, The Journal of bone and joint surgery. American volume.

Oxalosis in bone causing a radiographical mimicry of renal osteodystrophy.

B. Julian, H. Malluche, M. Faugere, 1987, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Evidence for abnormal calcium homeostasis in patients with adynamic bone disease.

H. Malluche, M. Monier‐Faugere, P. Roth, 1994, Kidney international.

Standardized nomenclature, symbols, and units for bone histomorphometry: A 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee

J. Kanis, F. Glorieux, R. Recker, 2013, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Abnormal bone histology in idiopathic hypercalciuria.

S. Massry, E. Ritz, H. Malluche, 1980, The Journal of clinical endocrinology and metabolism.

Improved assessment of bone turnover by the PTH-(1-84)/large C-PTH fragments ratio in ESRD patients.

H. Malluche, M. Monier‐Faugere, Z. Geng, 2001, Kidney international.

Calcitonin Alters Bone Quality in Beagle Dogs

A. Boskey, N. Camacho, H. Malluche, 1997, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Aluminum-related bone disease.

H. Malluche, M. Faugere, 1988, Blood purification.

Metabolic bone disease in patients on maintenance hemodialysis.

E. Ritz, H. Malluche, O. Mehls, 1974, Nephron.

Stainable aluminum and not aluminum content reflects bone histology in dialyzed patients.

H. Malluche, M. Faugere, 1986, Kidney international.

Aluminium and bone disease in chronic renal failure.

H. Malluche, Hartmut H Malluche, 2002, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

CKD-induced wingless/integration1 inhibitors and phosphorus cause the CKD-mineral and bone disorder.

B. Freedman, K. Hruska, H. Malluche, 2014, Journal of the American Society of Nephrology : JASN.

Diagnostic Accuracy of Bone Turnover Markers and Bone Histology in Patients With CKD Treated by Dialysis.

S. Moe, Aníbal Ferreira, V. Jorgetti, 2016, American journal of kidney diseases : the official journal of the National Kidney Foundation.

PTH regulation of the human cytomegalovirus immediate-early gene promoter.

N. Koszewski, H. Malluche, John P. Williams, 2008, Biochemical and biophysical research communications.

Suppression of the Human Parathyroid Hormone Promoter by Vitamin D Involves Displacement of NF-Y Binding to the Vitamin D Response Element*

N. Koszewski, H. Malluche, O. Park-Sarge, 2004, Journal of Biological Chemistry.

Targeted overexpression of insulin-like growth factor I to osteoblasts of transgenic mice: increased trabecular bone volume without increased osteoblast proliferation.

L. Donahue, T. Clemens, J. Fagin, 2000, Endocrinology.

Aluminum: toxin or innocent bystander in renal osteodystrophy.

H. Malluche, M. Faugere, 1985, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Structural and cellular assessment of bone quality of proximal femur.

L. Dorr, H. Malluche, T. Gruen, 1993, Bone.

Sclerostin and Dickkopf-1 in renal osteodystrophy.

A. Branscum, D. Fardo, H. Malluche, 2011, Clinical journal of the American Society of Nephrology : CJASN.

Evaluating bone quality in patients with chronic kidney disease

Hartmut H. Malluche, David Pienkowski, H. Malluche, 2013, Nature Reviews Nephrology.

The activin receptor is stimulated in the skeleton, vasculature, heart, and kidney during chronic kidney disease.

K. Hruska, H. Malluche, Yifu Fang, 2018, Kidney international.

Contrasting mammalian parathyroid hormone (PTH) promoters: nuclear factor-Y binds to a deoxyribonucleic acid element unique to the human PTH promoter and acts as a transcriptional enhancer.

N. Koszewski, H. Malluche, O. Park-Sarge, 2004, Endocrinology.

Sp3/Sp1 in the parathyroid gland: identification of an Sp1 deoxyribonucleic acid element in the parathyroid hormone promoter.

N. Koszewski, H. Malluche, M. C. Langub, 2003, Endocrinology.

The importance of bone health in end-stage renal disease: out of the frying pan, into the fire?

H. Malluche, M. Monier‐Faugere, H. Mawad, 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Differences in bone quality in low- and high-turnover renal osteodystrophy.

H. Malluche, D. Pienkowski, M. Monier‐Faugere, 2012, Journal of the American Society of Nephrology : JASN.

Peritonitis due to Exophiala jeanselmei in a patient undergoing continuous ambulatory peritoneal dialysis.

N. L. Goodman, H. Malluche, S. Agarwal, 1993, American journal of kidney diseases : the official journal of the National Kidney Foundation.

A new semiautomatic method for quantitative static and dynamic bone histology

Hartmut H. Malluche, David Sherman, Wolfang Meyer, 1982, Calcified Tissue International.

Uremic bone disease: current knowledge, controversial issues, and new horizons.

H. Malluche, M. Monier‐Faugere, 1991, Mineral and Electrolyte Metabolism.

Effects of 1,25(OH)2D3 administration on bone in patients with renal failure.

H. Malluche, M. Faugere, 1990, Kidney international. Supplement.

1,25(OH) 2 D 3 administration in moderate renal failure

H. Malluche, P. Fanti, M. Faugere, 1989 .

14 Renal Bone Disease

H. Malluche, M. Faugere, 1986 .

Update on vitamin D and its newer analogues: actions and rationale for treatment in chronic renal failure.

N. Koszewski, H. Malluche, H. Mawad, 2002, Kidney international.

Role of calcitriol in the management of osteoporosis.

H. Malluche, M. Faugere, 1990, Metabolism: Clinical and Experimental.

Values of noninvasive techniques in predicting bone histology.

H. Malluche, I. Arnala, M. Faugere, 1988, Annales chirurgiae et gynaecologiae.

Renal bone disease--an ongoing challenge to the nephrologist.

H. Malluche, 1995, Clinical nephrology.

Evidence of functional vitamin D receptors in rat hippocampus

J. P. Herman, J. Herman, N. Koszewski, 2001, Neuroscience.

Aluminum intoxication of bone in renal failure--fact or fiction?

H. Malluche, A. Smith, M. Faugere, 1986, Kidney international. Supplement.

Long-term effect of oral calcitriol pulse therapy on bone in hemodialysis patients.

Y. Tsukamoto, H. Malluche, M. Faugere, 1993, Bone.

Osteoblastic insufficiency is responsible for maintenance of osteopenia after loss of ovarian function in experimental beagle dogs.

H. Malluche, M. Faugere, R. Friedler, 1986, Endocrinology.

Molecular bone morphometry

H. Malluche, M. C. Langub, M. Faugere, 2000, Pediatric Nephrology.

Comparison between different methods of measurement of bone resorption

H. Malluche, M. Faugere, R. Juvin, 1992 .

A new bisphosphonate, BM 21.0955, prevents bone loss associated with cessation of ovarian function in experimental dogs

F. Bauss, H. Malluche, M. Monier‐Faugere, 1993, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Retinoic acid receptor gamma 2 interactions with vitamin D response elements

N. Koszewski, H. Malluche, J. Herberth, 2010, The Journal of Steroid Biochemistry and Molecular Biology.

Update on vitamin D and its newer analogues

H. Malluche, 2003 .

Isolation of genomic DNA sequences that bind vitamin D receptor complexes.

N. Koszewski, H. Malluche, S. Kiessling, 2001, Biochemical and biophysical research communications.

Characterization of vitamin D receptor immunoreactivity in human bone cells.

N. Koszewski, H. Malluche, R. Horst, 2000, Bone.

Parathyroid Hormone Type 1 Receptor and Human Osteoclasts

H. Malluche, M. Chris Langub, 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Bone — Normal Structure and Physiology

H. Malluche, M. Monier‐Faugere, M. C. Langub, 2002 .

Intermittent and Continuous Administration of the Bisphosphonate Ibandronate in Ovariohysterectomized Beagle Dogs: Effects on Bone Morphometry and Mineral Properties

A. Boskey, F. Bauss, H. Malluche, 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Intact PTH combined with the PTH ratio for diagnosis of bone turnover in dialysis patients: a diagnostic test study.

A. Branscum, H. Malluche, M. Monier‐Faugere, 2010, American journal of kidney diseases : the official journal of the National Kidney Foundation.

SIRT6 deficiency culminates in low-turnover osteopenia.

K. Hruska, H. Malluche, T. Sugatani, 2015, Bone.

Calcitonin prevents bone loss but decreases osteoblastic activity in ovariohysterectomized beagle dogs

H. Malluche, M. Monier‐Faugere, Z. Geng, 1996, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Endogenous calcitonin does not protect against hyperparathyroid bone disease in renal failure.

E. Ritz, H. Malluche, M. Faugere, 1986, Mineral and electrolyte metabolism.

Food and Drug Administration Center for Drug Evaluation and Research

Hartmut H. Malluche, George Ehrlich, Janet Woodcock, 1996 .

Young’s modulus and hardness of human trabecular bone with bisphosphonate treatment durations up to 20 years

H. Malluche, D. Pienkowski, C. Wood, 2018, Osteoporosis International.

Histomorphometric analysis of tricalcium phosphate ceramic implanted into turkeys.

H. Malluche, I. Arnala, M. Faugere, 1992, Bone.

A Survey Study of Self-Rated Patients’ Knowledge About AKI in a Post-Discharge AKI Clinic

Javier A. Neyra, J. Neyra, S. Silver, 2019, Canadian journal of kidney health and disease.

Bone changes occurring early after cessation of ovarian function in beagle dogs: A histomorphometric study employing sequential biopsies

H. Malluche, P. Fanti, M. Faugere, 1990, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[Use and indication of vitamin D and vitamin D analogues in patients with renal bone disease].

H. Malluche, N. Kubodera, 2002, Clinical calcium.

Secondary hyperparathyroidism and vitamin D receptor binding to vitamin D response elements in rats with incipient renal failure.

N. Koszewski, H. Malluche, M. Monier‐Faugere, 1997, Journal of the American Society of Nephrology : JASN.

Expression of DGCR8‐Dependent MicroRNAs Is Indispensable for Osteoclastic Development and Bone‐Resorbing Activity

K. Hruska, H. Malluche, B. Hildreth, 2014, Journal of cellular biochemistry.

Calcitriol corrects bone loss induced by oophorectomy in rats.

H. DeLuca, H. Malluche, M. Faugere, 1986, The American journal of physiology.

Bone Quality and Fractures in Women With Osteoporosis Treated With Bisphosphonates for 1 to 14 Years

H. Malluche, D. Pienkowski, M. Monier‐Faugere, 2021, JBMR plus.

Importance of bone turnover for therapeutic decisions in patients with CKD-MBD.

S. Ott, V. Jorgetti, H. Malluche, 2021, Kidney International.

Higher mineralized bone volume is associated with a lower plain X-Ray vascular calcification score in hemodialysis patients

Aníbal Ferreira, H. Malluche, A. Papoila, 2017, PloS one.

1,25-dihydroxyvitamin D3 corrects bone loss but suppresses bone remodeling in ovariohysterectomized beagle dogs.

H. Malluche, P. Fanti, M. Faugere, 1988, Endocrinology.

Short-term administration of the bisphosphonate ibandronate increases bone volume and prevents hyperparathyroid bone changes in mild experimental renal failure.

F. Bauss, H. Malluche, M. Monier‐Faugere, 2000, Clinical nephrology.

Effects of parathyroidectomy on circulating levels of 1 alpha,25-dihydroxyvitamin D and bone Gla protein in dialyzed patients.

H. Malluche, P. Fanti, R. Reitz, 1986, The Journal of clinical endocrinology and metabolism.

Transcription factor HNF4α2 promotes osteogenesis and prevents bone abnormalities in mice with renal osteodystrophy

T. Nickolas, H. Malluche, I. Salusky, 2023, The Journal of clinical investigation.

Prevention of bone disease in renal failure

H. Malluche, M. Faugere, L. Baker, 1991 .

Disturbed Synthesis of Type II Collagen Interferes with Rate of Bone Formation and Growth and Increases Bone Resorption in Transgenic Mice

H. Helminen, H. Malluche, M. Miettinen, 2008, Calcified Tissue International.

FGF-23 and sclerostin in serum and bone of CKD patients

H. Malluche, M. Monier‐Faugere, V. David, 2023, Clinical nephrology.

Trabecular bone microcrack accumulation in patients treated with bisphosphonates for durations up to 16 years

H. Malluche, D. Pienkowski, C. L. Wood, 2022, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

Absence of adynamic bone disease in African-Americans with CKD stage 5 after 3 years of vitamin D therapy guided by iPTH and the PTH-(1-84)/N-terminally truncated PTH fragments ratio.

J. Yee, H. Malluche, Y. Osman, 2009, Clinical nephrology.

Intestinal calcium absorption and whole-body calcium retention in various stages of renal insufficiency

H. Malluche, W. Schoeppe, E. Werner, 1975, Calcified Tissue Research.

8 Animal Models tor Osteoporosis

H. Malluche, J. B. Rodgers, 1994 .

Skeletal lesions and calcium metabolism in early renal failure.

Á. Gáti, E. Ritz, H. Malluche, 1975, Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association.

Disturbed Terminal Mineralization of Bone in Idiopathic Hypercalciuria

S. Massry, E. Ritz, H. Malluche, 1981 .

More on aluminum toxic effects in children with uremia.

H. Malluche, G. Zilleruelo, J. Strauss, 1990, The Journal of pediatrics.

Understanding and managing hyperphosphatemia in patients with chronic renal disease.

H. Malluche, Monier-Faugere Mc, 1999, Clinical nephrology.

Differences in bone quality in low- and high-turnover renal osteodystrophy.

H. Malluche, D. Pienkowski, M. Monier‐Faugere, 2012, Journal of the American Society of Nephrology : JASN.

Bone histomorphometry: Standardization of nomenclature, symbols, and units: Report of the asbmr histomorphometry nomenclature committee

M. Drezner, J. Kanis, F. Glorieux, 1987 .

Effects of sevelamer hydrochloride and calcium carbonate on renal osteodystrophy in hemodialysis patients.

Aníbal Ferreira, H. Malluche, C. Gil, 2008, Journal of the American Society of Nephrology : JASN.

Low-energy fractures without low T-scores characteristic of osteoporosis: a possible bone matrix disorder.

H. Malluche, D. Pienkowski, M. Monier‐Faugere, 2013, The Journal of bone and joint surgery. American volume.

Low Turnover Renal Osteodystrophy With Abnormal Bone Quality and Vascular Calcification in Patients With Mild-to-Moderate CKD

Habib Srour, H. Malluche, M. Issa, 2022, Kidney international reports.

Evaluating bone quality in patients with chronic kidney disease

H. Malluche, D. Pienkowski, D. S. Porter, 2013, Nature Reviews Nephrology.

Dose-dependent effects of aluminum on osteocalcin synthesis in osteoblast-like ROS 17/2 cells in culture.

S. Mohapatra, H. Malluche, M. Kindy, 1992, The American journal of physiology.